{"id":4663,"date":"2026-01-06T05:14:33","date_gmt":"2026-01-06T05:14:33","guid":{"rendered":"https:\/\/vertxnews.com\/?p=4663"},"modified":"2026-01-06T05:14:34","modified_gmt":"2026-01-06T05:14:34","slug":"rfk-jr-cdc-drop-6","status":"publish","type":"post","link":"https:\/\/vertxnews.com\/?p=4663","title":{"rendered":"RFK Jr., CDC Drop 6 Childhood Vaccines from Recommended List"},"content":{"rendered":"\n

In a landmark and highly debated move, the U.S. Centers for Disease Control and Prevention (CDC) has revised its childhood vaccine recommendations, trimming six vaccines from the widely followed immunization schedule. Spearheaded by Health and Human Services Secretary Robert F. Kennedy Jr. (RFK Jr.)<\/strong>, a figure known for his controversial views on vaccines, the decision marks one of the most dramatic shifts in U.S. public health policy in decades \u2014 and it\u2019s stirring intense debate among doctors, parents, and policymakers alike.<\/p>\n\n\n\n

This article breaks down what changed<\/strong>, why it happened<\/strong>, what vaccines were removed or repositioned<\/strong>, and what it means for your child\u2019s health<\/strong>. Our goal is to deliver clear, evidence-based insight in a human-friendly way \u2014 not fear, not fluff.<\/p>\n\n\n\n

\n\n\n\n

What Exactly Changed in the CDC\u2019s Vaccine Recommendations?<\/h2>\n\n\n\n

New Childhood Schedule: Fewer Universal Shots<\/h3>\n\n\n\n

The CDC has updated the childhood immunization schedule, reducing universally recommended vaccines from 17 to 11 diseases<\/strong>. Instead of broad recommendations for every child, six previously routine vaccines now fall under high-risk groups<\/strong> or are left to shared clinical decision-making<\/strong> with a healthcare provider. STAT+1<\/a><\/p>\n\n\n\n

Category<\/strong><\/th>Status Under New Schedule<\/strong><\/th><\/tr><\/thead>
Measles, Mumps, Rubella<\/td>Still universally recommended<\/td><\/tr>
Polio<\/td>Still universally recommended<\/td><\/tr>
Chickenpox (Varicella)<\/td>Still universally recommended<\/td><\/tr>
HPV (Human Papillomavirus)<\/td>Still universally recommended (1 dose)<\/em><\/td><\/tr>
Flu<\/td>No longer universally recommended (shared decision-making)<\/em><\/td><\/tr>
Rotavirus<\/td>No longer universally recommended (shared decision-making)<\/em><\/td><\/tr>
RSV (Respiratory Syncytial Virus)<\/td>Now recommended only for high-risk children<\/strong><\/td><\/tr>
Hepatitis A<\/td>Shifted to high-risk or shared decision<\/td><\/tr>
Hepatitis B<\/td>Shifted to high-risk or shared decision<\/td><\/tr>
Meningococcal Disease<\/td>Shifted to high-risk or shared decision<\/td><\/tr>
COVID-19 Vaccine<\/td>Removed from universal schedule<\/td><\/tr><\/tbody><\/table><\/div><\/figure>\n\n\n\n

Key takeaway:<\/strong> These vaccines are not banned<\/em> \u2014 they remain available, but parents and clinicians now play a more active role in deciding who should receive them. NBC New York<\/a><\/p>\n\n\n\n

\n\n\n\n

Why Did the CDC Change Its Vaccine Recommendations?<\/h2>\n\n\n\n

Presidential Directive & International Comparisons<\/h3>\n\n\n\n

The catalyst for this overhaul was a December 2025 Presidential Memorandum<\/strong> that asked the Department of Health and Human Services (HHS) to review how other developed nations structure their vaccination schedules. The goal, officials say, was to align U.S. recommendations with international peers and reduce what some policymakers described as \u201cover-vaccination.\u201d HHS<\/a><\/p>\n\n\n\n

Officials pointed to countries like Denmark, Japan, and Germany<\/strong>, which recommend fewer vaccines universally compared to previous U.S. policy \u2014 though experts note differences in healthcare systems, disease burden, and public health infrastructure make direct comparisons difficult. NBC New York<\/a><\/p>\n\n\n\n

RFK Jr.\u2019s Role and Policy Philosophy<\/h3>\n\n\n\n

As HHS Secretary, RFK Jr. supported this shift, emphasizing parental choice<\/strong>, transparency<\/strong>, and moving some decisions from government mandates to shared clinical discussions. This aligns with his long-standing critique of CDC vaccine policy and the traditional role of expert advisory panels. New York Post<\/a><\/p>\n\n\n\n

\n\n\n\n

What Vaccines Were Affected?<\/h2>\n\n\n\n

Six Vaccines Reclassified or Removed from the Recommended List<\/h3>\n\n\n\n
    \n
  1. Influenza (Flu)<\/strong> \u2013 shifted to shared clinical decision-making<\/li>\n\n\n\n
  2. Rotavirus<\/strong> \u2013 shifted to shared clinical decision-making<\/li>\n\n\n\n
  3. Respiratory Syncytial Virus (RSV)<\/strong> \u2013 recommended for high-risk groups<\/li>\n\n\n\n
  4. Hepatitis A<\/strong> \u2013 moved to high-risk\/shared decision category<\/li>\n\n\n\n
  5. Hepatitis B<\/strong> \u2013 no longer universal; now high-risk\/shared decision<\/li>\n\n\n\n
  6. Meningococcal Disease<\/strong> \u2013 high-risk\/shared decision<\/li>\n<\/ol>\n\n\n\n

    Additionally, the COVID-19 vaccine<\/strong> was removed from the universal list in separate changes earlier in 2025 \u2014 meaning healthy kids and pregnant women are no longer automatically recommended to receive it. Fierce Pharma+1<\/a><\/p>\n\n\n\n

    \n\n\n\n

    What \u201cShared Clinical Decision-Making\u201d Means<\/h2>\n\n\n\n

    This category signals that routine vaccination may be appropriate based on individual health factors<\/strong>, risk levels<\/strong>, and patient-clinician discussions<\/strong>. It\u2019s a middle ground between universal mandates and no recommendation at all. Shared decision-making is intended to personalize care \u2014 though critics worry it may reduce vaccination uptake.<\/p>\n\n\n\n

    \n\n\n\n

    Reactions from Medical and Public Health Experts<\/h2>\n\n\n\n

    How Experts Are Responding<\/h3>\n\n\n\n

    Public health professionals and organizations such as the American Academy of Pediatrics<\/strong> and the American Medical Association<\/strong> have strongly criticized the changes. They argue that:<\/p>\n\n\n\n